An ongoing dialogue on HIV/AIDS, infectious diseases,
January 3rd, 2012
Prevnar Now Approved for Adults — But Should We Start Using It?
From the FDA (and thanks to Physician’s First Watch for reporting the news): Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae. As shown in multiple studies, Prevnar has dramatically […]